期刊文献+

286株金黄色葡萄球菌临床分布及耐药性分析 被引量:8

Analysis on clinical distribution and drug resistance of 286 strains of Staphylococcus aureus
下载PDF
导出
摘要 目的分析2013年住院及门诊患者送检微生物培养标本分离得到的金黄色葡萄球菌临床分布及耐药性情况。方法对2013年分离得到的金黄色葡萄球菌进行细菌培养鉴定及药敏试验,并对结果进行分析。结果共分离得到286株金黄色葡萄球菌,耐甲氧西林金黄色葡萄球菌(MRSA)检出率为46.85%。呼吸道标本中的金黄色葡萄球菌和MRSA检出率均为最高。金黄色葡萄球菌主要分布于ICU、神经外科、创伤骨科、呼吸内科等临床科室。金黄色葡萄球菌对青霉素和氨苄西林耐药率较高,多数抗菌药物对甲氧西林敏感的金黄色葡萄球菌(MSSA)与MRSA的耐药率存在差异。结论监测金黄色葡萄球菌耐药性,对临床合理选择抗菌药物十分重要。 Objective To analyze the clinical distribution and drug resistance of Staphylococcus aureus isolated from the specimens of inpatient and outpatient in 2013.Methods All of the isolated Staphylococcus aureus were identified and tested drug sensitivity in 2013,and the results were analyzed.Results 286 strains of Staphylococcus aureus were isolated with the detection rate of MRSA accounting for 46.9%.The respiratory specimens had the highest detection rates of Staphylococcus aureus and MRSA.The isolated strains of Staphylococcus aureus were mainly distributed in ICU,Department of Neurosurgery,Department of Orthopedic trauma,and Department of Respiratory Medicine.The isolated Staphylococcus aureus had high drug resistant rates to penicillin and ampicillin.The drug resistant rates of most of the drugs were different between MSSA and MRSA.Conclusion Monitoring the drug resistance of Staphylococcus aureus is very important to rational choice of antimicrobial agents.
出处 《国际检验医学杂志》 CAS 2014年第22期3061-3063,共3页 International Journal of Laboratory Medicine
关键词 金黄色葡萄球菌 耐药性 甲氧西林 合理用药 Staphylococcus aureus drug resistant methicillin rational drug use
  • 相关文献

参考文献7

二级参考文献42

  • 1刘杨,吴菊芳,萧正伦,盛瑞媛,吕晓菊,陈燕,张婴元.1031例患者应用去甲万古霉素不良反应观察[J].中华内科杂志,2004,43(11):815-819. 被引量:46
  • 2朱德妹,张婴元,汪复,郭燕,蒋晓飞,倪语星,孙景勇,应春妹,汪雅萍,王传清,王爱敏,蒋燕群,汤瑾,张泓,李万华,沈燕雅,金文敏,周庭银,陈险峰,张蓓,黄卫春,杨海慧,卫颖珏,汤荣,丁星,吴丽桂,武楠,汪瑞忠,房华,吕新华,朱爱英.2009年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):403-413. 被引量:37
  • 3王辉,孙宏莉,陈民钧,胡必杰,俞云松,孙自庸,褚云卓,徐英春,谢秀丽.2005年我国五家教学医院革兰阳性球菌耐药监测研究[J].中华检验医学杂志,2006,29(10):873-877. 被引量:120
  • 4Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
  • 5Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
  • 6Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.
  • 7Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis-emergence of resistance in aerobic faecal gram-negative bacteria of in patients, but not among strains causing infection after elective colorectal procedures [J ]. Scand J Infect Dis, 1993, 25(6) :725-733.
  • 8Andaker L, Burman LG, Eklund A, et al. Fosfomycin/met- ronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective coloreetal surgery: a randomised double blind multicentre trial in 517 patients[J]. Eur J Surg, 1992, 158(3):181 185.
  • 9Nohr M, Andersen JC, Juul-Jensen KE. Prophylactic single dose fosfomycin and metronidazole compared with neomycin, haeitraein, metronidazole and ampicillin in elective colorectal operations[J]. Acta Chir Seand, 1990, 156(3):223-230.
  • 10Lindhagen J, Hadziomerovic A, Nordlung S, et al. Comparison of systemic prophylaxis with metronidazole-fosfomycin and met- ronidazole-cephalothin in elective colorectal surgery[J]. Acta Chir Scand, 1981, 147(4):277-283.

共引文献1210

同被引文献59

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部